Hemizygous or homozygous deletion of the chromosomal region containing the p16(INK4a) gene is associated with amplification of the EGF receptor gene in glioblastomas

International Journal of Cancer

Volumn 73, Issue 1, 1997, Pages 57-63

  Hegi, Monika E ^a   Zur Hausen, Axel ^a,b   Rüedi, Daniela ^a   Malin, Gerhard ^a   Kleihues, Paul ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; PROTEIN P16;

ARTICLE; CELL CYCLE; CHROMOSOME DELETION; GENE AMPLIFICATION; GENE MUTATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; FEMALE; GENE DELETION; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER;

EID: 1842330265     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970926)73:1<57::AID-IJC10>3.0.CO;2-2     Document Type: Article

References (36)

1. BIERNAT, W., AGUZZI, A., SURE, U., GRANT, J.W., KLEIHUES, P. and HEGI, M.E., Identical mutations in the p53 tumor suppressor gene in the glial and the sarcomutous components of gliosarcomas suggest a common origin from glial cells. J. Neuropathol. exp. Neurol., 54, 651-656 (1995).
2. BILZER, T., STAVROU, D., DAHME, E., KEIDITSCH, E., BÜRRIG, K.K. ANZIL, A.P. and WECHSLER, W., Morphological, immunocytochemical and growth characteristics of three human glioblastomasestablished in vitro. Virchow Arch. A. Pathol. Anat., 418, 281-293 (1991).
3. CONZEN, S.D. and COLE, C.N., Analysis of the p16 gene. CDKN2, in 17 Australian melanoma kindreds. Oncogene, 11, 2289-2294 (1995).
4. COSTELLO, J.F., BERGER, M.S., HUANG, H.-J.S. and CAVENEE, W.K., Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cencer Res., 56, 2405-2410 (1996).
5. INK4Bgene) during tumor progression in a sporadic melanoma patient. Cancer Res., 55, 5531-5535 (1995).
6. GONZALEZ-ZULUETA, M., BENDER, C.M., YANG, A.S., NGUYEN, T., BEART, R.W. and VAN TURNOUT, J.M., Methylation of the 5′-CpG island of the P16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55, 4531-4535 (1995).
7. GREGER, V., PASSARGE, E., HOPPING, W., MESSMER, E. and HORSTHEMKE, B., Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum. Genet., 83, 155-158 (1989).
8. HERMAN, J.G., LATIF, F., WENG, Y., LERMAN, M.J., ZBAR, B., LIU, S., SAMID, D., DUAN, D.-S.R., GNARRA, J.R., LINEHAN, W.M. and BAYLIN, S.B., Silencing of the VHL tumor-suppressor gene by DNA methylation in renal cell carcinoma. Proc. nat. Acad. Sci. (Wash.), 91, 9700-9704 (1994).
9. HINDS, P.W., MITTNACHT, S., DULIC, V., ARNOLD, A., REED, S.I. and WEINBERG, R.A., Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell, 70, 993-1006 (1992).
10. INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene, 13, 1065-1072 (1996).
11. ICHIMURA, K., SCHMIDT, E.E., YAMAGUCHI, N., JAMES, C.D. and COLLINS, V.P., A common region of homozygous deletion in malignant human glioma lies between the IFNα/o gene cluster and the D9S171 locus. Cancer Res., 54, 3127-3130 (1994).
12. JEN, J., HARPER, J.W., BIGNER, S.H., BIGNER, D.D., PAPADOPOULOS, N., MARKOWITZ, S., WILLSON, J.K.V., KINZLER, K.W. an VOGELSTEIN, B., Deletion of p16 and p15 genes in brain tumors. Cancer Res., 54, 6353-6358 (1994).
13. KAMB, A., GRUIS, N.A., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY, R.S.I., JOHNSON, B.E. and SKOLNICK, M.H., A cell cycle cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994).
14. KATHIB, Z.A., MATSUSHIME, H., VALENTINE, M., SHAPIRO, D.N., SHERR, C.J. and LOOK, A.T., Co-amplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res., 53, 5535-5541 (1993).
15. KATO, J., MATSUSHIME, H., HIEBERT, S.W., EWEN, M.E. and SHERR, C.J., Direct binding of cyclin D to the retinoblastoma gene product (pRb) and Rb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Develop., 7, 331-342 (1993).
16. KLEIHUES, P., BURGER, P.C. and SCHEITHAUER, B.W., Histological Typing of Tumours of the Central Nervous System Springer. New York (1993).
17. KYRITSIS, A.P., ZHANG, B., ZHANG, W., XIAO, M., TAKESHIMA, H., BONDY, M.L., CUNNINGHAM, J.E., LEVIN, V.A. and BRUNER, J., Mutations of the p16 gene in gliomas. Oncogene, 12, 63-67 (1996).
18. LANG, F.F., MILLER, D.C., KOSLOW, M. and NEWCOMB, E.W., Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J. Neurosurg., 81, 427-436 (1994).
19. INK4A transcript. Cancer Res., 55, 2995-2997 (1995).
20. MERLO, A., HERMAN, J.G., MAO, L., LEE, M.J., GABRIELSON, E., BURGER, P.C., BAYLIN, S.B. and SIDRANSKY, D., 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/ CDKN2/MTSI in human cancers. Nature (Med.), 1, 686-692 (1995).
21. NEUBAUER, A., NEUBAUER, B., HE, M., EFFERT, P., IGLEHART, D., FRYE, R.A. and LIU, E., Analysis of gene amplification in archival tissue by differential polymerase chain reaction. Oncogene, 7, 1019-1025 (1992).
22. INK4 expression is frequent in high grade gliomas. Cancer Res., 55, 1941-1945 (1995).
23. NOBORI, T., MIURAL, K., WU, D.J., TAKABAYASHI, K. and CARSON, D.A., Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368, 753-756 (1994).
24. OHGAKI, H., SCHÄUBLE, B., ZUR HAUSEN, A., VON AMMON, K. and KLEIHUES, P., Genetic alterations associated with the evolution and progression of astrocytic brain tumours. Virchows Arch. 427, 113-118 (1995).
25. INK4 in human cancer. Proc. nat. Acad. Sci. (Wash.), 91, 11045-11049 (1994).
26. ORITA, M., SUZUKI, Y., SEKIYA, T. and HAYASHI, K., Rapid and sensitive detection of point mutations und DNA polymorphisms using the polymerase chain reaction. Genomics, 5, 874-879 (1989).
27. INK4b genes. Oncogene, 11, 635-645 (1995a).
28. QUELLE, D.E., ZINDY, F., ASHMUN, R.A. and SHERR, C.J., Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, 83, 993-1000 (1995b).
29. REIFENBERGER, J., RING, G.U., GIES, U., COBBERS, J.M.J.L., OBERSTRASS, J., AN, H.-X., NIEDERACHER, D., WECHSLER, W. and REIFENBERGER, G., Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. J. Neuropathol. exp. Neurol., 55, 822-831 (1996).
30. SCHMIDT, E.E., ICHIMURA, K., REIFENBERGER, G. and COLLINS, V.P., CDKN2 (p16/MTSI) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res., 54, 6321-6324 (1994).
31. SERRANO, M., HANNON, G.J. and BEACH, D., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Science, 366, 704-707 (1993).
32. SERRANO, M., LEE, H.-W., CHIN, L., CORDON-CARDO, C., BEACH, D. and DEPINHO, R.A., Role of the INK4a locus in tumor suppression and cell mortality. Cell, 85, 27-37 (1996).
33. STONE, S., JIANG, P. DAYANANTH, P., TAVITGIAN, S.V., KATCHER, H., PARRY, D., GORDON, P. and KAMB, A., Complex structure and regulation of the p16 (MTSI) locus. Cancer Res., 55, 2988-2994 (1995).
34. VON DEIMLING, A., VON AMMON, K., SCHOENFELD, D., WIESTLER, O.D., SEIZINGER, B.R. and LOUIS, D.N., Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol., 3, 19-26 (1993).
35. WATANABE, K., TACHIBANA, O., SATO, K., YONEKAWA, Y., KLEIHUES, P. and OHGAKI, H., Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol., 6, 217-224 (1996).
36. WIEST, J.S. and 12 OTHERS, Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the locution of a putative tumor suppressor gene. Cancer Res., 57, 1-6 (1997).